Skip to main content

Table 3 Results of the association between TP73-AS1 and clinicopathological parameters

From: TP73-AS1 as a predictor of clinicopathological parameters and prognosis in human malignancies: a meta and bioinformatics analysis

Outcome

Studies

OR

95%CI

P value

Model

Heterogeneity

I2

P Value

Age (< 60 vs ≥ 60)

7

1.12

0.77–1.64

0.545

Fixed

36.7%

0.148

Gender (male vs female)

15

1.08

0.84–1.38

0.560

Fixed

0%

0.713

TNM stage (III-IV vs I-II)

12

3.27

2.43–4.39

 < 0.00001

Fixed

0%

0.526

tumor size (≥ 5 cm vs < 5 cm)

8

3.00

2.08–4.35

 < 0.00001

Fixed

0%

0.665

Lymph node metastasis (positive vs negative)

13

2.77

1.42–5.38

0.003

Random

78.5%

 ≤ 0.001

distant metastasis (yes vs no)

5

4.50

2.62–7.73

 < 0.00001

Fixed

0%

0.604

Differentiation (poor vs well)

9

1.39

0.71–2.70

0.340

Random

72.0%

 ≤ 0.001